Litcius/Paper detail

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020

Anna Jeffery-Smith, Nalini Iyanger, Sarah Williams, J. Yimmy Chow, Felicity Aiano, Katja Höschler, Angie Lackenby, Joanna Ellis, Steven G. Platt, Shahjahan Miah, Kevin Brown, Gayatri Amirthalingam, Monika Patel, Mary Ramsay, Robin Gopal, André Charlett, Shamez Ladhani, Maria Zambon

2021Eurosurveillance60 citationsDOIOpen Access PDF

Abstract

Two London care homes experienced a second COVID-19 outbreak, with 29/209 (13.9%) SARS-CoV-2 RT-PCR-positive cases (16/103 residents, 13/106 staff). In those with prior SARS-CoV-2 exposure, 1/88 (1.1%) individuals (antibody positive: 87; RT-PCR-positive: 1) became PCR-positive compared with 22/73 (30.1%) with confirmed seronegative status. After four months protection offered by prior infection against re-infection was 96.2% (95% confidence interval (CI): 72.7-99.5%) using risk ratios from comparison of proportions and 96.1% (95% CI: 78.8-99.3%) using a penalised logistic regression model.

Topics & Concepts

OutbreakMedicineConfidence intervalCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Logistic regressionAntibody2019-20 coronavirus outbreakInternal medicineImmunologyVirologyDiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies